Rxivist logo

Oncogenes are only transforming in certain cellular contexts, a phenomenon called oncogenic competence. The mechanisms regulating this competence remain poorly understood. Here, using a combination of a novel human pluripotent stem cell (hPSC)-based cancer model along with zebrafish transgenesis, we demonstrate that the transforming ability of BRAFV600E depends upon the intrinsic transcriptional program present in the cell of origin. Remarkably, in both systems, melanocytes (MC) are largely resistant to BRAF. In contrast, both neural crest (NC) and melanoblast (MB) populations are readily transformed. Molecular profiling reveals that NC/MB cells have markedly higher expression of chromatin modifying enzymes, and we discovered that the chromatin remodeler ATAD2 is required for response to BRAF and tumor initiation. ATAD2 forms a complex with SOX10, allowing for expression of downstream oncogenic programs. These data suggest that oncogenic competence is mediated by developmental regulation of chromatin factors, which then allow for proper response to those oncogenes. ### Competing Interest Statement L.S. is co-founder and consultant of BlueRock Therapeutics and is listed as inventor on patent application by MSKCC related to melanocyte differentiation from human pluripotent stem cells (WO2011149762A2). R.M.W. is a consultant to N-of-One, a subsidiary of Qiagen. All other authors declare no competing interests.

Download data

  • Downloaded 332 times
  • Download rankings, all-time:
    • Site-wide: 48,254 out of 88,613
    • In cancer biology: 1,525 out of 3,113
  • Year to date:
    • Site-wide: 7,163 out of 88,613
  • Since beginning of last month:
    • Site-wide: 9,965 out of 88,613

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)